NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
Episodes
Mentioned books
Dec 4, 2013 • 8min
NEJM Interview: Dr. Matthew Gillman on pre- and postnatal strategies for the prevention of childhood obesity.
Dr. Matthew Gillman is Professor and Director of the Obesity Prevention Program in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M.W. Gillman and D.S. Ludwig. How Early Should Obesity Prevention Start? N Engl J Med 2013;369:2173-5.
Nov 27, 2013 • 12min
NEJM Interview: Dr. Dan Barouch on researchers' ongoing quest to develop an HIV-1 vaccine.
Dr. Dan Barouch is the Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and Harvard Medical School and a Program Leader at the Reagan Institute of Massachusetts General Hospital, MIT, and Harvard University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.H. Barouch. The Quest for an HIV-1 Vaccine - Moving Forward. N Engl J Med 2013;369:2073-6.
Nov 20, 2013 • 11min
NEJM Interview: Dr. David Asch on the cost and value of medical education.
Dr. David Asch is a Professor of Medicine, Medical Ethics, and Health Policy at the University of Pennsylvania. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.A. Asch, S. Nicholson, and M. Vujicic. Are We in a Medical Education Bubble Market? N Engl J Med 2013;369:1973-5.
Nov 13, 2013 • 11min
NEJM Interview: Prof. Robert Huckman on publicly reported data and the shift towards consumerism in health care.
Prof. Robert Huckman is a Professor of Business Administration at the Harvard Business School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. R.S. Huckman and M.A. Kelley. Public Reporting, Consumerism, and Patient Empowerment. N Engl J Med 2013;369:1875-7.
Oct 30, 2013 • 17min
NEJM Interview: Prof. Sara Rosenbaum on the health care safety net, Medicaid expansion, and access to care.
Prof. Sara Rosenbaum is Professor of Health Law and Policy at the George Washington University School of Public Health and Health Services. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K. Neuhausen, M. Spivey, and A.L. Kellermann. State Politics and the Fate of the Safety Net. N Engl J Med 2013;369:1675-7.
Oct 16, 2013 • 8min
NEJM Interview: Dr. Peter Ubel on a new focus on informing patients about the likely out-of-pocket costs of care.
Dr. Peter Ubel is Professor of Business Administration and Medicine and of Public Policy at Duke University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. P.A Ubel, A.P. Abernethy, and S.Y. Zafar. Full Disclosure - Out-of-Pocket Costs as Side Effects. N Engl J Med 2013;369:1484-6.
Oct 9, 2013 • 11min
NEJM Interview: Dr. Ingrid Katz on the transition from PEPFAR-funded to government-funded HIV care in South Africa.
Dr. Ingrid Katz is from the Division of Women's Health, Infectious Diseases, and Medical Communications at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. I.T. Katz, I.V. Bassett, A.A. Wright. PEPFAR in Transition - Implications for HIV Care in South Africa. N Engl J Med 2013;369:1385-7.
Sep 25, 2013 • 12min
NEJM Interview: Dr. Gerard O'Donoghue on the past and future development of cochlear implants.
Dr. Gerard O'Donoghue is Honorary Professor of Otology and Neurotology at the University of Nottingham and Consultant Neurotologist at Queen's Medical Centre in Nottingham, England. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. G. O'Donoghue. Cochlear Implants - Science, Serendipity, and Success. N Engl J Med 2013;369:1190-3.
Sep 18, 2013 • 14min
NEJM Interview: Dr. Richard Schwartzstein on the pros and cons of three-year medical school programs.
Dr. Richard Schwartzstein is a Professor of Medicine and Medical Education at Harvard Medical School, Director of the HMS Academy for Teaching Excellence and Educational Innovation, and Associate Chief of the Division of Pulmonary and Critical Care Medicine at Beth Israel Deaconess Medical Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. S.B. Abramson and Others. A 3-Year M.D. - Accelerating Careers, Diminishing Debt. N Engl J Med 2013;369:1085-7. S. Goldfarb and G. Morrison. The 3-Year Medical School - Change or Shortchange? N Engl J Med 2013;369:1087-9.
Sep 11, 2013 • 9min
NEJM Interview: Dr. Troyen Brennan on one chain pharmacy's initiative to curb abuse of controlled substances.
Dr. Troyen Brennan is the Executive Vice President and Chief Medical Officer of CVS Caremark. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M. Betses and T. Brennan. Abusive Prescribing of Controlled Substances - A Pharmacy View. N Engl J Med 2013;369:989-91.
